GET HELP NOW

Wednesday, September 6, 2017

Synthetic version of popular anticoagulant poised for clinical trials

http://ift.tt/eA8V8J A synthetic version of low molecular weight heparin is poised for clinical trials and development as a drug for patients with clotting disorders, and those undergoing procedures such as kidney dialysis, heart bypass surgery, stent implantation, and knee and hip replacement.

from Latest Science News -- ScienceDaily http://ift.tt/2vMOPmZ
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Children whose mothers use marijuana are more likely to try it at younger age

When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...